Abilify recalls

Abilify products have been recalled 5 times, most recently on 1 May 2024. The recalling company is usually Second Tokushima Factory, Otsuka Pharmaceutical Co. The most common reason is packaging defects.

Total recalls5since 2013

Last 12 months0reported

Class I00% of total

Ongoing4latest 1 May 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 1 20%Class III 4 80%

Why abilify is recalled

Packaging Defects480%
Manufacturing (CGMP) Deviations120%

Companies

By year

2024480%
2013120%

Ongoing abilify recalls

4 active

Reported	Class	Recall	Company	Reason	Where
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide

All abilify recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory, Otsuka Pharmaceutical Co	Packaging Defects	Nationwide
13 Mar 2013Drug	CLASS II	Abilify (aripiprazole) Tablets, 30 mg recalled by Bristol Myers SquibbAbilify	Bristol Myers Squibb Manufacturing	Manufacturing (CGMP) Deviations	CA, LA, TN

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.